Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bluefish pharmaceuticals ab - fexofenadinhydroklorid - filmdragerad tablett - 180 mg - fexofenadinhydroklorid 180 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bluefish pharmaceuticals ab - fexofenadinhydroklorid - filmdragerad tablett - 120 mg - fexofenadinhydroklorid 120 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

amarox pharma b.v - fexofenadinhydroklorid - filmdragerad tablett - 120 mg - fexofenadinhydroklorid 120 mg aktiv substans; laktosmonohydrat hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

amarox pharma b.v - fexofenadinhydroklorid - filmdragerad tablett - 180 mg - fexofenadinhydroklorid 180 mg aktiv substans; laktosmonohydrat hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

accord healthcare b.v. - fludarabinfosfat - koncentrat till injektions-/infusionsvätska, lösning - 25 mg/ml - mannitol hjälpämne; fludarabinfosfat 25 mg aktiv substans - fludarabin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

fresenius kabi oncology plc - fludarabinfosfat - pulver till injektions-/infusionsvätska, lösning - 50 mg - fludarabinfosfat 50 mg aktiv substans; mannitol hjälpämne - fludarabin

Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

mylan ireland limited - abirateronacetat - prostatiska neoplasmer - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europeiska unionen - svenska - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateronacetat - prostatiska neoplasmer - endokrin terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

docpharma nv - fexofenadinhydroklorid - filmdragerad tablett - 120 mg - fexofenadinhydroklorid 120 mg aktiv substans - fexofenadin